Hantz Financial Services Inc. Reduces Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Hantz Financial Services Inc. lessened its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 23.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 138 shares of the medical instruments supplier’s stock after selling 43 shares during the quarter. Hantz Financial Services Inc.’s holdings in Mettler-Toledo International were worth $169,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Robeco Institutional Asset Management B.V. boosted its position in Mettler-Toledo International by 18.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after acquiring an additional 5,234 shares during the last quarter. Slow Capital Inc. boosted its holdings in shares of Mettler-Toledo International by 0.6% during the 4th quarter. Slow Capital Inc. now owns 2,256 shares of the medical instruments supplier’s stock worth $2,760,000 after purchasing an additional 14 shares during the last quarter. Pacer Advisors Inc. grew its position in shares of Mettler-Toledo International by 17.7% in the fourth quarter. Pacer Advisors Inc. now owns 4,569 shares of the medical instruments supplier’s stock valued at $5,591,000 after purchasing an additional 687 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Mettler-Toledo International in the fourth quarter valued at approximately $1,616,000. Finally, Blue Trust Inc. lifted its position in Mettler-Toledo International by 70.8% during the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock worth $50,000 after buying an additional 17 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 140 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on MTD. Robert W. Baird cut their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Finally, Wolfe Research started coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Stock Up 0.1 %

Shares of MTD opened at $1,365.36 on Friday. Mettler-Toledo International Inc. has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93. The firm’s 50 day moving average price is $1,267.00 and its 200 day moving average price is $1,343.65. The company has a market cap of $28.81 billion, a P/E ratio of 36.81, a PEG ratio of 4.72 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Research analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.